Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Tytuł pozycji:

Peptide-based scaffolds for the culture and maintenance of primary human hepatocytes.

Tytuł:
Peptide-based scaffolds for the culture and maintenance of primary human hepatocytes.
Autorzy:
MacPherson D; Department of Medicine, Weill Cornell Medical College, 413 E 69th St, New York, NY, 10021, USA.
Bram Y; Department of Medicine, Weill Cornell Medical College, 413 E 69th St, New York, NY, 10021, USA.
Park J; Department of Medicine, Weill Cornell Medical College, 413 E 69th St, New York, NY, 10021, USA.
Schwartz RE; Department of Medicine, Weill Cornell Medical College, 413 E 69th St, New York, NY, 10021, USA. .; Department of Physiology, Biophysics, and Systems Biology, Weill Cornell Medical College, 413 E 69th St, New York, NY, 10021, USA. .
Źródło:
Scientific reports [Sci Rep] 2021 Mar 24; Vol. 11 (1), pp. 6772. Date of Electronic Publication: 2021 Mar 24.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Język:
English
Imprint Name(s):
Original Publication: London : Nature Publishing Group, copyright 2011-
MeSH Terms:
Peptides*/chemistry
Primary Cell Culture*/methods
Tissue Scaffolds*/chemistry
Hepatocytes/*cytology
Hepatocytes/*metabolism
Arginine/analogs & derivatives ; Aspartic Acid/analogs & derivatives ; Biomarkers ; Cell Adhesion ; Cell Survival ; Fluorenes ; Gene Expression ; Glycine/analogs & derivatives ; Humans
References:
Science. 2005 Nov 18;310(5751):1139-43. (PMID: 16293750)
Soft Matter. 2008;4(12):2310-2315. (PMID: 20198120)
Nat Biotechnol. 2005 Jan;23(1):47-55. (PMID: 15637621)
Sci Rep. 2015 Aug 07;5:13079. (PMID: 26248878)
Biotechnol Bioeng. 2009 Jul 1;103(4):655-63. (PMID: 19472329)
Science. 1993 May 14;260(5110):920-6. (PMID: 8493529)
Biotechnol Adv. 2014 Mar-Apr;32(2):504-13. (PMID: 24440487)
J Hepatol. 2001 Jan;34(1):11-8. (PMID: 11211886)
Adv Healthc Mater. 2015 Jan 7;4(1):131-141. (PMID: 24753455)
J Struct Biol. 2009 Sep;167(3):216-9. (PMID: 19481153)
Chem Soc Rev. 2014 Dec 7;43(23):8150-77. (PMID: 25199102)
Adv Healthc Mater. 2014 Sep;3(9):1387-91. (PMID: 24659615)
Biomaterials. 2009 May;30(13):2523-30. (PMID: 19201459)
Proteomics. 2010 May;10(9):1886-90. (PMID: 20162561)
Chem Commun (Camb). 2015 Jun 30;51(56):11260-3. (PMID: 26081605)
Acta Biomater. 2009 Mar;5(3):934-43. (PMID: 19249724)
Science. 2005 Nov 18;310(5751):1135-8. (PMID: 16293749)
Hepat Med. 2010 May 25;2:49-67. (PMID: 24367208)
Arch Toxicol. 2013 Aug;87(8):1315-530. (PMID: 23974980)
Cell. 1986 Feb 28;44(4):517-8. (PMID: 2418980)
Science. 2002 Feb 8;295(5557):1009-14. (PMID: 11834815)
Nat Chem Biol. 2013 Aug;9(8):514-20. (PMID: 23728495)
Nat Biotechnol. 2008 Jan;26(1):120-6. (PMID: 18026090)
Semin Immunol. 2008 Apr;20(2):86-100. (PMID: 18162407)
Acta Biomater. 2016 Dec;46:29-40. (PMID: 27677593)
Adv Healthc Mater. 2017 Aug;6(15):. (PMID: 27901316)
Biomacromolecules. 2018 Mar 12;19(3):825-837. (PMID: 29389119)
Biomaterials. 1996 Feb;17(3):373-85. (PMID: 8745335)
Cell. 2006 Aug 25;126(4):677-89. (PMID: 16923388)
Tissue Eng Part A. 2012 Jan;18(1-2):176-84. (PMID: 21827280)
J Nanobiotechnology. 2010 Dec 12;8:29. (PMID: 21143997)
Nat Mater. 2016 Jan;15(1):13-26. (PMID: 26681596)
Nat Mater. 2003 May;2(5):329-32. (PMID: 12704382)
Tissue Eng Part A. 2008 Feb;14(2):227-36. (PMID: 18333775)
Sci Rep. 2015 Nov 23;5:16884. (PMID: 26592180)
Biophys J. 2007 Aug 15;93(4):1255-63. (PMID: 17526569)
Front Biosci (Landmark Ed). 2011 Jan 01;16:225-50. (PMID: 21196168)
Methods Mol Biol. 2013;945:287-302. (PMID: 23097113)
ACS Biomater Sci Eng. 2015 Jun 8;1(6):431-439. (PMID: 26240838)
J Lab Autom. 2015 Jun;20(3):216-50. (PMID: 25617027)
Grant Information:
R01 DK121072 United States DK NIDDK NIH HHS; R03 DK117252 United States DK NIDDK NIH HHS; R01 CA234614 United States CA NCI NIH HHS; R01 AI107301 United States AI NIAID NIH HHS
Substance Nomenclature:
0 (Biomarkers)
0 (Fluorenes)
0 (Fmoc-RGD)
0 (Peptides)
30KYC7MIAI (Aspartic Acid)
94ZLA3W45F (Arginine)
TE7660XO1C (Glycine)
Entry Date(s):
Date Created: 20210325 Date Completed: 20211022 Latest Revision: 20211215
Update Code:
20240105
PubMed Central ID:
PMC7990934
DOI:
10.1038/s41598-021-86016-5
PMID:
33762604
Czasopismo naukowe
We report here the use of a nanofibrous hydrogel as a 3D scaffold for the culture and maintenance of functional primary human hepatocytes. The system is based on the cooperative assembly of a fiber-forming peptide component, fluorenylmethyloxycarbonyl-diphenylalanine (Fmoc-FF), and the integrin-binding functional peptide ligand, Fmoc-arginine-glycine-aspartic acid (Fmoc-RGD) into a nanofibrous gel at physiological pH. This Fmoc-FF/RGD hydrogel was formulated to provide a biomimetic microenvironment with some critical features such as mechanical properties and nanofiber morphology, which were optimized to support hepatocyte culture. The material was shown to support maintenance and function of encapsulated primary human hepatocytes as indicated by actin staining, qRT-PCR, and functional cytochrome P450 assays. The designed gel was shown to outperform Matrigel in cytochrome P450 functional assays. The hydrogel may prove useful for liver development and disease models, as well as providing insights into the design of future implantable scaffolds for the regeneration of liver tissue in patients with liver disease.

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies